Cashu
Impending Supreme Leader Selection in Iran Raises Stakes for U.S.-Iran Relations
2 days ago
Stocks
Health Care
asmb
Assembly Biosciences
NASDAQ: ASMB
-0.08 (-0.27%)
29.52
USD
At close at Mar 11, 15:08 UTC
Overview
Loading chart...
Key Stats
Market Cap
227.10M
Dividend Yield
0.00%
P/E Ratio
-5.89
EPS
-6.72
Revenue
-
Avg. Volume
102.36K
About
What does ASMB do?
Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.